Aberrant p53, mdm2, and Proliferation differ in glioblastomas from long-term compared with typical survivors. - Burton,E.C.; Lamborn,K.R.; Forsyth,P.; Scott,J.; O’Campo,J.; Uyehara-Lock,J.; Prados,M.; Berger,M.; Passe,S.; Uhm,J.; O’Neill,BP.; Jenkins,R.B.; et al. (Clin Cancer Res, 2002)